Private insurance companies and plan sponsors companies that provide prescription drug coverage to their workers spent more on drugs and devices for diabetes than for any other category of illness in 2025, according to a recent Telus Health report
BI identified profiles such as Dr
This article examines the safety profile of concurrent use, practical guidance for patients, and alternative pain management options to help you make informed decisions in consultation with your healthcare provider
Think of semaglutide as a tool that works with your bodys biology, not against it
Be available to your attorney as they build and file your case with the appropriate court
A recent phase 2 trial testing doses of up to 16 mg/week suggests that, while higher doses yield further improvements in blood glucose and body weight, there is no clinical justification for exceeding the approved dose of 2 mg/week due to increased frequency of AEs